Effect of Yinhuangsan (YHS) on Diabetic Foot Ulcers (DFU): A Systematic Review and Meta-Analysis
- 1 Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
- 2 The First Affiliated Hospital of Shantou University Medical College, Shantou, China
- 3 Shenzhen Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen, China
- 4 Shenzhen Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen, China
- 5 The First Affiliated Hospital of Shantou University Medical College, Shantou, China
Abstract
Objectives: To assess the safety and effectiveness of Yinhuangsan (YHS) in patients with diabetic foot ulcers (DFU). Search Methods: Studies were selected from PubMed (1966 to January 2021), the Excerpta Medica Database (EMBASE) (1974 to January 2021), the Cochrane Library (1988 to January 2021), SinoMed (CBM) (1978 to January 2021), China Science and Technology Journal Data-base (VIP) (1994 to January 2021), Wanfang Data Knowl-edge Service Platform (1998 to January 2021) and the China National Knowledge Infrastructure (CNKI) (1984 to January 2021). No language restrictions were applied. Studies were identified and selected, and the data were extracted independently by two reviewers. The Cochrane Risk of Bias tool was used to assess the quality of studies. Revman 5.3 software was used for data synthesis and analysis. Results: Two studies were included based on the selection criteria. Two trials were of unsatisfied methodological quality and adopting different criteria to judge outcomes. As such, we were unable to perform a summary meta-analysis but concentrated on a narrative summary of results. Both the included studies had a low risk of incomplete data bias and selective reporting bias, while neither of them mentioned allocation concealment and blinding. Both two trials showed positive results favoring YHS compared with positive controls independently in total effective rate. One reported amputation rate, mortality and ulcer area change, and the other described ulcer healing rate. Neither of the trials stated adverse reactions and quality of life. Conclusions: There is currently inadequate evidence on evaluating YHS for DFU effectively, due to the paucity of randomized controlled trials and the low methodological quality in included studies. The safety of YHS remains unknown for lack of ample data on adverse events. Hence, YHS should be applied with caution. More high quality randomized controlled trials (RCTs) expected to strengthen the evidence for the effectiveness and safety of YHS treating DFU are in demand. Standardized monitoring or a valid reporting system should be adopted to critically estimate adverse events and the safety in the future.
- Cuttica, D.J. and Philbin, T.M. (2010) Surgery for Diabetic Foot Infections. Foot and Ankle Clinics, 15, 465-476. https://doi.org/10.1016/j.fcl.2010.03.006
- Basu, M.S., Jayashree, B.S. and Shenoy, R.R. (2018) Epigenetic Modulation of Macrophage Polarization-Perspectives in Diabetic Wounds. Journal of Diabetes and Its Complications, 32, 524-530. https://doi.org/10.1016/j.jdiacomp.2018.01.015
- Zhang, P., Jing, Y., et al. (2017) Global Epidemiology of Diabetic Ulceration: A Systematic Review and Meta-Analysis. Annals of Medicine, 49, 106-116. https://doi.org/10.1080/07853890.2016.1231932
- Lazzarini, P.A., Hurn, S.E., Fernando, M.E., et al. (2015) Prevalence of Foot Disease and Risk Factors in General Inpatient Populations: A Systematic Review and Meta-Analysis. BMJ Open, 5, e008544. https://doi.org/10.1136/bmjopen-2015-008544
- International Diabetes Federation (2017) IDF Diabetes Atlas. 8th Edition, Brussels.
- Bakker, K., Apelqvist, J., Lipsky, B.A., et al. (2016) The 2015 IWGDF Guidance Documents on Prevention and Management of Foot Problems in Diabetes: Development of an Evidence-Based Global Consensus. Diabetes/Metabolism Research and Reviews, 32, 2-6. https://doi.org/10.1002/dmrr.2694
- Jupiter, D.C., Thorud, J.C., Buckley, C.J. and Shibuya, N. (2016) The Impact of Foot Ulceration and Amputation on Mortality in Diabetic Patients. I: From Ulceration to Death, a Systematic Review. International Wound Journal, 13, 892-903. https://doi.org/10.1111/iwj.12404
- Brennan, M.B., Hess, T.M., Bartle, B., Cooper, J.M., Kang, J., Huang, E.S., et al. (2017) Diabetic Foot Ulcer Severity Predicts Mortality among Veterans with Type 2 Diabetes. Journal of Diabetic Complications, 31, 556-561. https://doi.org/10.1016/j.jdiacomp.2016.11.020
- Raghav, A., Khan, A., Labala, R.K., et al. (2018) Financial Burden of Diabetic Foot Ulcers to World: A Progressive Topic to Discuss Always. Therapeutic Advances in Endocrinology and Metabolism, 9, 29-31. https://doi.org/10.1177/2042018817744513
- Hicks, C.W., Selvarajah, S., Mathioudakis, N., et al. (2016) Burden of Infected DFU on Hospital Admissions and Costs. Annals of Vascular Surgery, 33, 149-158. https://doi.org/10.1016/j.avsg.2015.11.025
- Diabetes Branch of Chinese Medical Association, Infectious Diseases Branch of Chinese Medical Association, Tissue Repair and Regeneration Branch of Chinese Medical Association (2019) Guidelines for the Prevention and Treatment of Diabetic Foot in China (2019 Edition). Chinese Journal of Diabetes Mellitus, 11, 92-108.